Antonius A. Miller

Prospective evaluation of the relationship of patient age and paclitaxel clinical pharmacology: Cancer and Leukemia Group B (CALGB 9762).

G. Rosner, M. Ratain, D. Hollis, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pharmacology of 21-day oral etoposide given in combination with i.v. cisplatin in patients with extensive-stage small cell lung cancer: a cancer and leukemia group B study (CALGB 9062).

G. Rosner, R. Schilsky, M. Ratain, 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

Phase II study of carboplatin, irinotecan, and thalidomide in patients with advanced non-small cell lung cancer (NSCLC).

J. Atkins, A. Miller, J. Giguere, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Schedule dependency of 21-day oral versus 3-day intravenous etoposide in combination with intravenous cisplatin in extensive-stage small-cell lung cancer: a randomized phase III study of the Cancer and Leukemia Group B.

J. Herndon, D. Hollis, M. Green, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.